Nir Naor

Director, BRAINSTORM CELL THERAPEUTICS INC.

Companies

Neuronetics, Inc.Chief financial officer Jul 23, 2026 to now¹
BRAINSTORM CELL THERAPEUTICS INC.Board member Jun 21, 2023 to now²
Axogen, Inc.Chief financial officer Jan 4, 2024 to Jan 6, 2025³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Axogen, Inc. AXGN260,868 shares⁴$9.0M at $34.62Jan 6, 2025
Neuronetics, Inc. STIM500,000 shares⁵$986.0K at $1.97Jul 23, 2026
BRAINSTORM CELL THERAPEUTICS INC. BCLI31,465 shares⁶$24.5K at $0.78Jan 1, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 23, 2026Granted 500,000 shares of Neuronetics, Inc.⁵
Jan 6, 2025Shares withheld for tax 39,132 shares at $15.22 of Axogen, Inc.⁴
Jan 1, 2025Granted 30,666 shares of BRAINSTORM CELL THERAPEUTICS INC.⁶
Jan 1, 2024Granted 300,000 shares of Axogen, Inc.⁷
Jun 19, 2023Granted 11,999 shares of BRAINSTORM CELL THERAPEUTICS INC.⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNeuronetics, Inc., Chief financial officer
2
SEC EDGARBRAINSTORM CELL THERAPEUTICS INC., Board member
3
SEC EDGARAxogen, Inc., Chief financial officer
4
SEC EDGARAxogen, Inc. shares after the filing of Jan 6, 2025
5
SEC EDGARNeuronetics, Inc. shares after the filing of Jul 23, 2026
6
SEC EDGARBRAINSTORM CELL THERAPEUTICS INC. shares after the filing of Jan 1, 2025
7
SEC EDGARForm 4 filed Jan 4, 2024
8
SEC EDGARForm 4 filed Jun 21, 2023